Frontlight ResearchEarly access
Taking peopleNo phase
Early WAKE-up Predictors After Out-of-Hospital Cardiac Arrest
Key facts
- Who runs it
- University of Aarhus
- Where
- Denmark2 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 250 people, planned
- Started
- 13 May 2025
- Expected to end
- Dec 2027
- Type of study
- Observational
- Treatments tested
- Automated Pupillometry
- Transcranial Doppler Ultrasound
- Optic Nerve Sheath Diameter
- Continuous EEG and EEG Reactivity
- Record updated
- 18 November 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 22 criteriaShow less
Who can take part
- Age ≥18 years
- OHCA of presumed cardiac cause
- Sustained ROSC, defined as persistent signs of circulation and no need for chest compressions or mechanical circulatory support for 20 minutes
- Unconsciousness (GCS <9) (patients not able to obey verbal commands) after sustained ROSC at the time of randomization
Who cannot take part
- Known limitations in therapy and Do Not Resuscitate-order
- Systolic blood pressure <80 mm Hg despite fluid loading/vasopressor and/or inotropic medication (If the systolic blood pressure is recovering during the inclusion window of 180 minutes the patient may be included)
- Ongoing (within 48 h) treatment with olanzapine or dexamethasone
- Known bleeding diathesis (medically induced coagulopathy (e.g. warfarin, NOAC, clopidogrel) does not exclude the patient)
- Suspected or confirmed acute intracranial bleeding
- Suspected or confirmed acute stroke
- Known disease making 180 days survival unlikely
- Known allergy for dexamethasone or olanzapine
- Known back or hip condition that precluded the patients from being positioned with backrest from 0 to 45-degree angle
- Known active fungal disease. Localized skin lesions do not exclude patients from inclusion
- Known or suspected Long QT Syndrome (LQTS)
- Females of childbearing potential if pregnancy is suspected (unless a negative HCG test can rule out pregnancy within the inclusion window)
- Unwitnessed asystole
- Known pre-arrest CPC 3 or 4 functional status
- >3 hours (180 minutes) from ROSC to screening
- Use of intra-aortic balloon pump/axial flow device/ECMO (If the patient is weaned and the device is removed during the inclusion window of 180 minutes the patient may be included)
- Temperature on admission <30°C
- Estimated body weight <45kg
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
WAKE-OHCA is a prospective observational substudy of the Danish Out-of-Hospital Cardiac Arrest (DANOHCA) trial, identifier NCT05895838. The aim is to collect early neuromonitoring data to identify key predictors of successful wake-up.
Treatments tested
- Automated Pupillometry
- Transcranial Doppler Ultrasound
- Optic Nerve Sheath Diameter
- Continuous EEG and EEG Reactivity
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Early Wake-up Predictors After Out-of-hospital Cardiac Arrest - an Observational, Multicenter Substudy of the DANOHCA Trial
- Record updated
- 18 November 2025